vs
Side-by-side financial comparison of INNO HOLDINGS INC. (INHD) and Scinai Immunotherapeutics Ltd. (SCNI). Click either name above to swap in a different company.
INNO HOLDINGS INC. is the larger business by last-quarter revenue ($1.5M vs $773.0K, roughly 1.9× Scinai Immunotherapeutics Ltd.). On growth, INNO HOLDINGS INC. posted the faster year-over-year revenue change (635.6% vs 172.2%).
INNOvative Retail BV, is an upmarket Belgian department store chain that operates sixteen branches around Belgium.
INHD vs SCNI — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5M | $773.0K |
| Net Profit | $-28.6K | — |
| Gross Margin | 5.1% | — |
| Operating Margin | -33.4% | — |
| Net Margin | -2.0% | — |
| Revenue YoY | 635.6% | 172.2% |
| Net Profit YoY | 95.3% | — |
| EPS (diluted) | $-0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5M | — | ||
| Q3 25 | $1.1M | — | ||
| Q2 25 | $1.1M | $773.0K | ||
| Q1 25 | $478.1K | — | ||
| Q4 24 | $196.0K | — | ||
| Q3 24 | $490.0K | — | ||
| Q2 24 | — | $284.0K | ||
| Q1 24 | $183.2K | — |
| Q4 25 | $-28.6K | — | ||
| Q3 25 | $-1.3M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-3.6M | — | ||
| Q4 24 | $-603.7K | — | ||
| Q3 24 | $-287.2K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-1.1M | — |
| Q4 25 | 5.1% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | -1.5% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -33.4% | — | ||
| Q3 25 | -89.7% | — | ||
| Q2 25 | -143.7% | — | ||
| Q1 25 | -286.4% | — | ||
| Q4 24 | -233.7% | — | ||
| Q3 24 | 87.7% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -150.9% | — |
| Q4 25 | -2.0% | — | ||
| Q3 25 | -120.5% | — | ||
| Q2 25 | -142.4% | — | ||
| Q1 25 | -757.3% | — | ||
| Q4 24 | -308.0% | — | ||
| Q3 24 | -58.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -578.9% | — |
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $5.03 | — | ||
| Q2 25 | $-0.30 | — | ||
| Q1 25 | $-0.83 | — | ||
| Q4 24 | $-5.21 | — | ||
| Q3 24 | $-0.14 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-0.51 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.1M | $989.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $47.2M | $7.9M |
| Total Assets | $47.3M | $11.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.1M | — | ||
| Q3 25 | $10.1M | — | ||
| Q2 25 | $4.4M | $989.0K | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $4.8M | — | ||
| Q3 24 | $1.1M | — | ||
| Q2 24 | — | $3.1M | ||
| Q1 24 | $4.0M | — |
| Q4 25 | $47.2M | — | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $8.0M | $7.9M | ||
| Q1 25 | $7.1M | — | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $2.8M | — | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | $4.1M | — |
| Q4 25 | $47.3M | — | ||
| Q3 25 | $16.0M | — | ||
| Q2 25 | $8.8M | $11.8M | ||
| Q1 25 | $7.3M | — | ||
| Q4 24 | $10.7M | — | ||
| Q3 24 | $4.2M | — | ||
| Q2 24 | — | $14.9M | ||
| Q1 24 | $7.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.0M | — | ||
| Q3 25 | $-1.0M | — | ||
| Q2 25 | $-594.8K | — | ||
| Q1 25 | $-1.0M | — | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $-660.2K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-2.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $-795.1K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-3.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -1083.3% | — | ||
| Q3 24 | -162.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1720.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.7% | — | ||
| Q3 24 | 27.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 118.1% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
